Personalis combines expertise both in the technology of sequencing and in interpretation, with an extensive history of peer reviewed publication and commercial success. Broad adoption of medical genome interpretation will require accuracy befitting regulatory approval, both in variant detection and interpretation. More than half of the founding team are MDs, and this reflects the company's commitment to serious medically-focused results, at quality standards eventually suitable for regulatory approval and insurance reimbursement. The team includes experienced PhD scientists, who know that the research community also cares deeply about accuracy, thoroughly substantiated and peer-reviewed. Personalis has exclusively licensed key intellectual property originating in the labs of the founders. Lastly, the Personalis team includes business people with decades of experience in genetic analysis, who know that the democratization of genome sequencing will also require high-quality customer support for interpretation, lab by lab, genome after genome.
Menlo Park, US
86 (est)+4%

Key People at Personalis

Chris Schaepe

Chris Schaepe

Carol J. Tillis

Carol J. Tillis

Vice President Finance and Administration
Christian Haudenschild

Christian Haudenschild

Senior Director of Genomic Services
Michael Fitzpatrick

Michael Fitzpatrick

Vice President Worldwide Sales

Personalis Locations

Menlo Park, US
West Wickham, GB

Personalis Metrics

Personalis Summary

Founding Date


Total Funding

$75 M

Latest funding size

$22 M

Time since last funding

about 3 years


Lightspeed Venture Partners, Mohr Davidow Ventures, Abingworth, Lightspeed Venture Partners, Mohr Davidow Ventures, Abingworth

Personalis Online Presence

Personalis Company Life